BACKGROUND: Preeclampsia is a prevalent and enigmatic disease, in part characterized by poor remodeling of the spiral arteries. However, preeclampsia does not always clinically present when remodeling has failed to occur. Hypotheses surrounding the "second hit" that is necessary for the clinical presentation of the disease focus on maternal inflammation and oxidative stress. Yet, the studies to date that have investigated these factors have used cross-sectional study designs or small study populations. OBJECTIVE: In the present study, we sought to explore longitudinal trajectories, beginning early in gestation, of a panel of inflammation and oxidative stress markers in women who went on to have preeclamptic or normotensive pregnancies. STUDY DESIGN: We examined 441 subjects from the ongoing LIFECODES prospective birth cohort, which included 50 mothers who experienced preeclampsia and 391 mothers with normotensive pregnancies. Participants provided urine and plasma samples at 4 time points during gestation (median, 10, 18, 26, and 35 weeks) that were analyzed for a panel of oxidative stress and inflammation markers. Oxidative stress biomarkers included 8-isoprostane and 8-hydroxydeoxyguanosine. Inflammation biomarkers included C-reactive protein, the cytokines interleukin-1b, -6, and -10, and tumor necrosis factor-a. We created Cox proportional hazard models to calculate hazard ratios based on time of preeclampsia diagnosis in association with biomarker concentrations at each of the 4 study visits. RESULTS: In adjusted models, hazard ratios of preeclampsia were significantly (P<.01) elevated in association with all inflammation
BACKGROUND: Preeclampsia is a prevalent and enigmatic disease, in part characterized by poor remodeling of the spiral arteries. However, preeclampsia does not always clinically present when remodeling has failed to occur. Hypotheses surrounding the "second hit" that is necessary for the clinical presentation of the disease focus on maternal inflammation and oxidative stress. Yet, the studies to date that have investigated these factors have used cross-sectional study designs or small study populations. OBJECTIVE: In the present study, we sought to explore longitudinal trajectories, beginning early in gestation, of a panel of inflammation and oxidative stress markers in women who went on to have preeclamptic or normotensive pregnancies. STUDY DESIGN: We examined 441 subjects from the ongoing LIFECODES prospective birth cohort, which included 50 mothers who experienced preeclampsia and 391 mothers with normotensive pregnancies. Participants provided urine and plasma samples at 4 time points during gestation (median, 10, 18, 26, and 35 weeks) that were analyzed for a panel of oxidative stress and inflammation markers. Oxidative stress biomarkers included 8-isoprostane and 8-hydroxydeoxyguanosine. Inflammation biomarkers included C-reactive protein, the cytokines interleukin-1b, -6, and -10, and tumor necrosis factor-a. We created Cox proportional hazard models to calculate hazard ratios based on time of preeclampsia diagnosis in association with biomarker concentrations at each of the 4 study visits. RESULTS: In adjusted models, hazard ratios of preeclampsia were significantly (P<.01) elevated in association with all inflammation biomarkers that were measured at visit 2 (median, 18 weeks; hazard ratios, 1.31e1.83, in association with an interquartile range increase in biomarker). Hazard ratios at this time point were the most elevated for Creactive protein, for interleukin-1b, -6, and -10, and for the oxidative stress biomarker 8-isoprostane (hazard ratio, 1.68; 95% confidence interval, 1.14e2.48) compared to other time points. Hazard ratios for tumor necrosis factor-a were consistently elevated at all 4 of the study visits (hazard ratios, 1.49e1.63; P<.01). In sensitivity analyses, we observed that these associations were attenuated within groups typically at higher risk of experiencing preeclampsia, which include African American mothers, mothers with higher body mass index at the beginning of gestation, and pregnancies that ended preterm. CONCLUSIONS: This study provides the most robust data to date on repeated measures of inflammation and oxidative stress in preeclamptic compared with normotensive pregnancies. Within these groups, inflammation and oxidative stress biomarkers show different patterns across gestation, beginning as early as 10 weeks. The start of the second trimester appears to be a particularly important time point for the measurement of these biomarkers. Although biomarkers alone do not appear to be useful in the prediction of preeclampsia, these data are useful in understanding the maternal inflammatory profile in pregnancy before the development of the disease and may be used to further develop an understanding of potentially preventative measures. P reeclampsia is a hypertensive disorder of pregnancy that is characterized by high blood pressure in combination with proteinuria after 20 weeks gestation. 1 Although some risk factors are known, understanding of the underlying biologic mechanisms remains limited. Some evidence, however, points toward a role of maternal inflammation and oxidative stress. For example, some investigators have hypothesized that an important difference of preeclampsia vs normal or growthrestricted pregnancy is due to, at least in part, an overwhelming inflammatory stimulus or hyperresponsive state in the mother. 2 Oxidative stress could also play a role in the cause of preeclampsia through multiple pathways. 3, 4 First, reactive oxygen species can cause apoptosis of the syncytiotrophoblast during the placentation process and impair the normal arteriolar remodeling. 5, 6 Second, oxidative stress could cause, conflate, or be the consequence of the altered inflammatory response in preeclamptic pregnancies. Finally, oxidative stress has been hypothesized to activate maternal endothelial cells as a precursor to preeclampsia. 7 How, why, and when these conditions develop remain important and unanswered questions. It is unclear whether the inflammatory or oxidative stress responses are local to the intrauterine compartment or are systemic in nature. A number of studies have examined circulating or excreted biomarkers in an attempt to answer these questions. In the present analysis, we focus on the question of "when." By examining repeated measures of oxidative stress and inflammation biomarkers at 4 study visits, we explored trajectories in these levels over time in preeclamptic compared with normotensive pregnancies. Additionally, we estimate hazard ratios in association with levels of these biomarkers at each time point to quantify Original Research OBSTETRICS ajog.org the risk of preeclampsia that is associated with these levels in certain windows of pregnancy. Although we hypothesized that inflammation and oxidative stress biomarkers would be elevated in mothers who went on to experience preeclampsia, our investigation of timing was exploratory in nature.
Materials and Methods

Study population
The ongoing LIFECODES birth cohort began recruitment in 2006 at Brigham and Women's Hospital (BWH) in Boston, MA. Under the study design, women who plan to deliver at BWH are recruited early in pregnancy (<15 weeks gestation) at tertiary care centers in the Boston area. 8 At baseline (median, 10 weeks gestation), women provide questionnaire data, urine and blood samples, and informed consent. Gestational age is assessed according to guidelines of the American College of Obstetricians and Gynecologists, 9 with last menstrual period verified by first-trimester ultrasound scanning. Additional questionnaire data and samples are collected at 3 subsequent study visits (median, 18, 26, and 35 weeks gestation). After delivery, details of the pregnancy progression and any complications are abstracted from medical records. The birth cohort study received institution review board approval from BWH.
The present analysis used subjects from a case-control study of preterm birth that included participants from LIFECODES recruited between 2006 and 2008. This study captured all women who delivered at <37 weeks gestation (n¼130) and roughly 3:1 unmatched control subjects (delivery, 37 weeks gestation; n¼352). The primary objective of this study was to examine the relationship between environmental contaminants and preterm birth. In the present analysis, as a secondary objective, we sought to examine the role of oxidative stress and inflammation in preeclampsia within these participants.
A diagnosis of preeclampsia and a diagnosis date were abstracted from medical records. Preeclampsia was defined according to American College of Obstetricians and Gynecologists' clinical guidelines by elevated maternal blood pressure after 20 weeks gestation (140 mm Hg systolic or 90 mm Hg diastolic) in combination with proteinuria (>300 mg/24 hours or protein/creatinine ratio >0.20).
1 All cases of preterm preeclampsia received 24-hour proteinuria tests, although other cases were diagnosed according to the ratio. All potential cases of preeclampsia were verified by 2 maternal-fetal medicine specialists; if the specialists disagreed on the diagnoses, a third specialist reviewed the case. We identified 50 cases of preeclampsia, 31 of whom delivered preterm. We included cases of superimposed preeclampsia (n¼9) but excluded 1 case of postpartum preeclampsia. For the present analysis, we excluded participants with other gestational hypertensive disorders so as to provide a clean comparison of inflammation and oxidative stress profiles in preeclamptic vs normotensive pregnancies (n¼24 with gestational hypertension; n¼16 with chronic hypertension who did not experience preeclampsia). This allowed for a final samples size of 441 pregnancies (preeclamptic pregnancies, 50; normotensive pregnancies, 391).
Biomarker measurement
Plasma from each of the 4 study visits was stored at e80 C until shipment to the University of Michigan for analysis of inflammation biomarkers at the Cancer Center Immunology Core. C-reactive protein (CRP) was measured with the use of enzyme-linked immunosorbent assay and was detectable to 10 mg/mL. A panel of cytokines, including interleukin (IL)-1b, -6, and -10, and tumor necrosis factor-a (TNF-a) was assayed with the use of the Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead ajog.org
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Panel (EMD Millipore Corp, St. Charles, MO). The limit of detection was 0.128 pg/mL for all cytokines. Urine samples were stored similarly at e80 C until analysis. Cayman Chemical Company (Ann Arbor, MI) measured 8-hydroxydeoxyguanosine (8-OHdG) and total 8-isoprostane via enzyme immunoassay. For 8-isoprostane, urine samples first underwent affinity purification. To account for urine dilution, we measured specific gravity using a digital handheld refractometer (Atago Co, Ltd, Tokyo, Japan). For presenting distributions of urinary biomarkers, we created corrected 8-OHdG and 8-isoprostane concentrations as described elsewhere. 10 For statistical models, we included uncorrected oxidative stress biomarker concentrations and treated specific gravity as a covariate. We excluded implausible 8-OHdG concentrations (n¼3 observations). All laboratory analyses were blinded to the case status of the participants. Inflammation and oxidative stress measures below the limit of detection were replaced with the limit of detection divided by the square root of 2.
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Statistical analysis
All statistical analyses were performed using R (version 3.2.3) and were weighted with the use of inverse probability weightings based on the probability of preterm vs term selection for the case-control study so that the results would be generalizable to the base BWH population. Population characteristics were tabulated for preeclamptic and normotensive pregnancies, and differences in distributions were tested using a Chi square test for independence. Distributions of inflammation and oxidative stress biomarkers in preeclamptic pregnancies compared with normotensive pregnancies at visit 1 were examined with the use of selected percentiles. Additionally, we created generalized additive mixed models with a random intercept for each subject to model each biomarker as predicted by splined gestational age at sample collection, with an interaction term for preeclampsia. From these models, we created predicted value plots of each biomarker across gestation for preeclamptic and normotensive pregnancies.
To quantify the association between the biomarkers that were measured and preeclampsia, we performed time-toevent analyses using Cox proportional hazards models, estimating hazards ratios (HRs) of preeclampsia. As mentioned earlier, these analyses were weighted so that the distribution of preeclampsia in each model was comparable with that in the base BWH population. Each model included 1 ln-transformed biomarker either from 1 study visit or a geometric average created from levels measured at visits 1e3 modeled in relation to gestational age at the diagnosis of preeclampsia or gestational age at delivery. The average measured was created as a more stabilized metric of subject-specific inflammation or oxidative stress biomarkers over pregnancy, because individual biomarkers demonstrate moderate variability over time. 10, 12 We created unadjusted models and models adjusted for covariates that were (1) selected a priori (maternal age and race/ethnicity) or (2) associated with both preeclampsia and the biomarker of interest in bivariate analyses and influenced effect estimates by >10%. For oxidative stress markers, we additionally created a model that was adjusted for specific gravity alone for comparison. We tested the proportional hazards assumption using the survival package in R. 13 In sensitivity analyses, we examined effect modification by maternal demographic or behavioral factors that previously have demonstrated differential susceptibility to preeclampsia.
Results
In the present study population, women who experienced preeclampsia were more likely to be obese (body mass index [BMI], >30 kg/m 2 ) at the first study visit, to have used assisted reproductive technology (ART) to get pregnant, to deliver preterm, and to be carrying a male fetus (Table 1) . Of these variables, we previously observed that urinary 8-isoprostane and plasma CRP, IL-6, and TNF-a concentrations were higher in obese, compared with normal weight, subjects.
12,14 For ART, both oxidative stress biomarkers were slightly lower in mothers who conceived using ART compared with those who conceived Inflammation biomarker concentrations by gestational age in preeclamptic vs. normotensive pregnancies Predicted value (A), CRP and (B), TNF-alpha from generalized additive mixed models of lntransformed inflammation biomarker concentrations in relation to Loess-smoothed gestational age at sample collection with an interaction term for preeclampsia. Models include a random intercept for each subject and are weighted for generalizability to the base cohort population. Solid lines represent predicted values; dashed lines represent lower and upper 95% confidence limits for each group. Red polygon highlights concentrations in mothers who experienced in preeclampsia, and gray polygon highlights concentrations in mothers who had normotensive pregnancies. Points represent actual biomarker concentrations.
CRP, C-reactive protein; TNF-a, tumor necrosis factor-alpha. Original Research OBSTETRICS ajog.org naturally. No differences in any of the biomarkers were observed by fetal sex. Thus, we considered maternal age, race/ ethnicity, BMI at visit 1, and ART as covariates in Cox proportional hazards models.
Mothers who went on to experience preeclampsia had higher levels of CRP, TNF-a, and 8-isoprostane early in pregnancy, at a median of 10 weeks gestation (Table 2) . Generalized additive mixed models showed that an interaction term between preeclampsia and gestational age at sample collection was significant in models that predicted CRP, TNF-a, and specific gravity corrected 8-OHdG, but not specific gravity corrected 8-isoprostane (Figures 1 and 2 for inflammation and oxidative stress biomarkers, respectively). CRP levels appeared to be most disparate in preeclamptic and normotensive pregnancies early in pregnancy but were more similar toward the end of gestation. TNF-a concentrations were consistently higher in cases of preeclampsia across pregnancy. In regard to oxidative stress biomarkers, urinary 8-OHdG concentrations were uniformly lower across pregnancy in preeclamptic pregnancies, although 8-isoprostane concentrations showed a greater difference between preeclamptic and normotensive pregnancies early in gestation.
Results for unadjusted models (model 1) and models adjusted for maternal race/ethnicity and BMI at visit 1 (model 2) were similar for inflammation biomarkers, with some attenuation of effect estimates in adjusted models (Table 3) . CRP at visit 2 (median, 18 weeks gestation; 25th percentile, 17 weeks gestation;75th percentile, 19 weeks gestation) showed the strongest association with preeclampsia (adjusted HR, 1.83; 95% CI, 1.33e2.51). TNF-a was associated most consistently with increased HRs across gestation. Other cytokines, as with CRP, showed strongest associations at visit 2.
In sensitivity analyses for inflammation markers, we examined effect modification by maternal smoking, BMI at visit 1, race/ethnicity, fetal sex, and preterm birth. The greatest differences were observed by maternal smoking status during pregnancy. Mothers who smoked had significantly larger HRs for the association between all inflammation biomarkers, except for IL-1b and preeclampsia, despite the low number of smokers in this population (with preeclampsia, 5; with normotensive pregnancy, 21). For preterm birth, HRs for CRP, IL-1b, and IL-6 were lower in cases compared with control subjects, but interaction terms were imprecise.
HRs for associations between 8-OHdG and preeclampsia were inverse consistently across models that were unadjusted (model 1), adjusted for specific gravity only (model 2), and additionally adjusted for BMI at visit 1 and use of ART (model 3; Table 4 ). In fully adjusted models, effect estimates were similar in magnitude and statistically significant for 8-OHdG levels from each of the 4 study visits.
Contrary to the findings for 8-OHdG, 8-isoprostane was associated consistently with an increase in HR of preeclampsia (Table 4) . HRs were elevated across pregnancy, but the highest HR was observed in association with levels measured at visit 2. In sensitivity analyses, we observed that demographic categories that typically are associated with higher 8-isoprostane levels (including obese, black, other race/ ethnicity, preterm, and smokers) had significantly lower HR (ie, closer to the null) for the association between 8-isoprostane and preeclampsia. As examples, smoothed plots of HR in association with average 8-isoprostane over pregnancy by preterm birth and BMI are displayed in Figure 3 .
Comment
We examined the relationship between a panel of inflammation and oxidative stress biomarkers that were measured at up to 4 time points during pregnancy in relation to risk of the development of preeclampsia. We observed consistent positive associations between inflammation markers and HRs, with the strongest associations observed at approximately 18 weeks of pregnancy for most biomarkers; however, for TNF-a, HRs were elevated consistently at all 4 time points in pregnancy. Similarly, 8-isoprostane, which is a biomarker of lipid peroxidation and oxidative stress, was associated with elevated HRs consistently across pregnancy. Finally, 8-OHdG, which is also thought to be indicative of oxidative stress but more Oxidative stress biomarker concentrations by gestational age in preeclamptic vs. normotensive pregnancies Predicted values for (A) 8-OHdG and (B) 8-isoprostane from generalized additive mixed models of lntransformed specific gravity corrected oxidative stress biomarker concentrations in relation to Loesssmoothed gestational age at sample collection with an interaction term for preeclampsia. Models include a random intercept for each subject and are weighted for generalizability to the base cohort population. Solid lines represent predicted values; dashed lines represent lower and upper 95% confidence limits for each group. Red polygon highlights concentrations in mothers who experienced in preeclampsia and gray polygon highlights concentrations in mothers who had normotensive pregnancies. Points represent actual biomarker concentrations. ajog.org OBSTETRICS Original Research specifically of oxidative DNA damage, was found to be protective against preeclampsia with consistent findings over gestation.
A number of studies have examined inflammation markers during pregnancy in relation to preeclampsia. Those reports that have measured inflammatory biomarkers at 1 time during pregnancy have largely supported our findings that mothers with preeclampsia have higher serum or plasma levels of CRP, IL-6, IL-10, and TNF-a during gestation. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] These have been primarily small case-control studies with blood samples collected later in gestation or at delivery, after the disease status is known. Studies with contrary findings had major design differences, such as measurement of cytokines in placentae 28 or examination of preeclampsia only without severe features. 29 However, a recent analysis of a multiplex panel of inflammation biomarkers that were analyzed in serum samples from approximately 16 weeks gestation was largely null. 30 One other study to date has examined longitudinal profiles of cytokines in preeclamptic compared with normotensive pregnancies (preeclampsia, 32 cases; control subjects, 67) and observed the greatest effect estimates for TNF-a and IL-6 later in pregancy. 31 As with inflammation, several studies have examined oxidative stress biomarkers in the context of preeclampsia. [32] [33] [34] For urinary 8-isoprostane, 1 small casecontrol study examined 3 repeated measures during gestation and observed no associations with measures from any of the points. 34 However, a more recent cross-sectional study with a larger sample size and urine samples collected at approximately 12 weeks gestation demonstrated that the proportion of subjects with preeclampsia increased in a dose-dependent manner with increasing urinary 8-isoprostane quintile. 33 Our study suggests that timing of sample collection, characteristics of the mothers, and severity of preeclampsia may contribute to these differences in previous findings. These findings could be particularly important for understanding the impact of antioxidant supplementation in the prevention of preeclampsia, which has Hazard ratios of preeclampsia in association with an interquartile range difference in inflammation biomarker strong biologic plausibility 6 but has not been demonstrated in clinical trials. 35 Most trials focus on recurrent preeclampsia to obtain a larger numbers of cases, but these mothers are more likely to have preterm preeclampsia 36 that was not associated with oxidative stress levels in our study.
Previous work that has examined maternal urinary 8-OHdG in relation to preeclampsia have been null 33, 37 ; however, 1 study observed a suggestive but nonsignificant trend of higher proportions of participants with preeclampsia in lower quintiles of urinary 8-OHdG concentrations, which is in accordance with our findings. 33 This surprisingly may be explained by impaired DNA excision repair processes in mothers with preeclampsia. 33 Alternatively, decreased levels of 8-OHdG in urine from preeclamptic mothers may be due to higher levels of accumulation in the placenta, which has been reported in multiple studies. 38, 39 Our sensitivity analyses provided several novel insights into the relationship between inflammation and oxidative stress biomarkers and the development of preeclampsia. We observed that individuals who delivered preterm had HRs that were closer to the null for 8-isoprostane and several inflammation markers, which could suggest that inflammation and oxidative stress may play a more important role in the cause of less severe preeclampsia and that other mechanisms are at play in the more severe cases that result in preterm delivery. This finding is consistent with our other analyses in this population, in which we observed null associations between these biomarkers and preterm birth that was placentally mediated. 10, 12 This is supportive of different phenotypes for preeclampsia, which should be considered carefully when studying the cause of this complex disease.
Demographic and behavioral factors impacted associations in the present analysis as well. African American pregnancies had attenuated associations among CRP, IL-6, and 8-isoprostane and preeclampsia compared with white women (data not shown). Also, subjects ajog.org OBSTETRICS Original Research with a higher BMI had lower associations between 8-isoprostane and preeclampsia compared with subjects with normal BMI, which could suggest a buffering effect, because individuals in these categories tend to have higher background levels of inflammation and oxidative stress, as indicated by levels of these biomarkers in this and other study populations. 10, 12 The strengths of this study were the availability of repeated measures of oxidative stress and inflammation across gestation, the use of high sensitivity assays, and the ability to generalize our findings to the pregnant population in the Boston area. We were limited by sample size and power, particularly in sensitivity analyses, because of our use of a preexisting case-control study of preterm birth. We also were unable to examine potentially relevant confounders, such as diet. Nevertheless, this is 1 of the strongest studies to date to examine biomarkers of inflammation and oxidative stress in pregnancy prospectively in relation to the development of preeclampsia.
In conclusion, inflammation and oxidative stress biomarkers show different patterns across pregnancy, beginning as early as 10 weeks gestation, in mothers who go on to experience preeclampsia compared with those who have a normotensive pregnancy. The start of the second trimester shows the greatest differences in these biomarkers between the 2 groups. Furthermore, elevated levels of systemic inflammation and oxidative stress are most apparent in mothers who have term, rather than preterm, preeclampsia, and it would behoove future research studies to explore these groups further separately when attempting to understand mechanisms. Although biomarkers alone do not appear to predict preeclampsia, 40 these data are useful in understanding the maternal inflammatory profile in pregnancy before the development of the disease and may be used to further develop potentially preventative measures. n
